These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 16838605)
41. [Achievements in morphological diagnosis of prostatic cancer: alpha-methylacyl-coenzyme-A-racemase--a new marker of malignant cell transformation]. Pozharisskiĭ KM; Leenman EE; Arzumanov AA Arkh Patol; 2005; 67(5):15-9. PubMed ID: 16323473 [TBL] [Abstract][Full Text] [Related]
42. Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Wu CL; Yang XJ; Tretiakova M; Patton KT; Halpern EF; Woda BA; Young RH; Jiang Z Hum Pathol; 2004 Aug; 35(8):1008-13. PubMed ID: 15297968 [TBL] [Abstract][Full Text] [Related]
43. Microcystic adenocarcinoma of the prostate: a variant of pseudohyperplastic and atrophic patterns. Yaskiv O; Cao D; Humphrey PA Am J Surg Pathol; 2010 Apr; 34(4):556-61. PubMed ID: 20216381 [TBL] [Abstract][Full Text] [Related]
44. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia. Mirtti T; Alanen K; Kallajoki M; Rinne A; Söderström KO Prostate; 2003 Mar; 54(4):290-8. PubMed ID: 12539227 [TBL] [Abstract][Full Text] [Related]
45. Characterization of reactive stroma in prostate cancer: involvement of growth factors, metalloproteinase matrix, sexual hormones receptors and prostatic stem cells. Silva MM; Matheus WE; Garcia PV; Stopiglia RM; Billis A; Ferreira U; Fávaro WJ Int Braz J Urol; 2015; 41(5):849-58. PubMed ID: 26689510 [TBL] [Abstract][Full Text] [Related]
46. Detection of alpha-methylacyl-coenzyme A racemase in postradiation prostatic adenocarcinoma. Yang XJ; Laven B; Tretiakova M; Blute RD; Woda BA; Steinberg GD; Jiang Z Urology; 2003 Aug; 62(2):282-6. PubMed ID: 12893336 [TBL] [Abstract][Full Text] [Related]
47. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Weinstein MH; Signoretti S; Loda M Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011 [TBL] [Abstract][Full Text] [Related]
48. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study. Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321 [TBL] [Abstract][Full Text] [Related]
49. Changes in biomarker expression in the development of prostatic adenocarcinoma. Myers RB; Grizzle WE Biotech Histochem; 1997 Mar; 72(2):86-95. PubMed ID: 9152521 [TBL] [Abstract][Full Text] [Related]
50. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Zhou M; Jiang Z; Epstein JI Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580 [TBL] [Abstract][Full Text] [Related]
51. [Value of the antibody cocktail anti p63 + anti p504s for the diagnosis of prostatic cancer]. Molinié V; Hervé JM; Lebret T; Lugagne-Delpon PM; Saporta F; Yonneau L; Botto H; Baglin AC Ann Pathol; 2004 Feb; 24(1):6-16. PubMed ID: 15192532 [TBL] [Abstract][Full Text] [Related]
52. Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia? Hailemariam S; Vosbeck J; Cathomas G; Zlobec I; Mattarelli G; Eichenberger T; Zellweger T; Bachmann A; Gasser TC; Bubendorf L Hum Pathol; 2011 May; 42(5):702-9. PubMed ID: 21237492 [TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical detection of carcinoma in radical prostatectomy specimens following hormone therapy. Kusumi T; Koie T; Tanaka M; Matsumoto K; Sato F; Kusumi A; Ohyama C; Kijima H Pathol Int; 2008 Nov; 58(11):687-94. PubMed ID: 18844933 [TBL] [Abstract][Full Text] [Related]
54. Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapy. Dalfior D; Delahunt B; Brunelli M; Parisi A; Ficarra V; Novara G; Novella G; Gobbo S; Valotto C; Chilosi M; Menestrina F; Martignoni G Pathology; 2010 Jan; 42(1):1-5. PubMed ID: 20025473 [TBL] [Abstract][Full Text] [Related]
55. [Assessment of P504S immunohistochemistry in diagnosis and differential diagnosis of prostatic adenocarcinoma]. Chen GY; Liu LN; Zhou XG; Zhang CH; Huang SF Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):419-23. PubMed ID: 15498210 [TBL] [Abstract][Full Text] [Related]
56. Prostate cancer with aberrant diffuse p63 expression: report of a case and review of the literature and morphologic mimics. Wu A; Kunju LP Arch Pathol Lab Med; 2013 Sep; 137(9):1179-84. PubMed ID: 23991727 [TBL] [Abstract][Full Text] [Related]
57. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. De Marzo AM; Marchi VL; Epstein JI; Nelson WG Am J Pathol; 1999 Dec; 155(6):1985-92. PubMed ID: 10595928 [TBL] [Abstract][Full Text] [Related]